Vivo Capital’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Vivo Capital’s Portfolio ASLN Stock Details ASLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-71,023	Closed	-$1.07M	–	54
2023 Q3	$1.07M	Sell	71,023 -284,091	-80%	-$5.21M	0.12%	47
2023 Q2	$10.4M	Hold	355,114	–	–	0.72%	23
2023 Q1	$1.64M	Buy	355,114 +284,091	+400%	+$7.68M	0.11%	41
2022 Q4	$1.02M	Hold	71,023	–	–	0.12%	43
2022 Q3	$1.7M	Hold	71,023	–	–	0.19%	47
2022 Q2	$1.41M	Hold	71,023	–	–	0.14%	46
2022 Q1	$2.56M	Hold	71,023	–	–	0.18%	48
2021 Q4	$3.18M	Hold	71,023	–	–	0.19%	49
2021 Q3	$5.06M	Hold	71,023	–	–	0.23%	51
2021 Q2	$9.38M	Hold	71,023	–	–	0.41%	42
2021 Q1	$9.52M	Buy	+71,023	New	+$9M	0.33%	42

Other funds holding ASLN

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

LCM

Landscape Capital Management Englewood, New Jersey $1.54B AUM 30.95% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Waterfront Wealth Overland Park, Kansas $645M AUM 27.59% 1-Year Est. Return

Vivo Capital's ASLN Position: Q4 2023 in Review

Vivo Capital sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q4 2023, closing a stake of 71,023 shares — an estimated $1.07M sold.

Vivo Capital first reported a position in ASLN in Q1 2021 and held it in 11 quarters. The position peaked at $10.4M in Q2 2023. 22 funds tracked by Wall St. Rank hold ASLN as of Q4 2023.

Vivo Capital reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q4 2023 after selling out during the quarter.
Vivo Capital sold 71,023 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q4 2023, an estimated $1.07M.
Vivo Capital first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q1 2021 and held it in 11 quarters.
Vivo Capital's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $10.4M in Q2 2023.
22 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q4 2023.

Based on Vivo Capital's 13F filing for Q4 2023, filed 7 Feb 2024.